COPD — all decisions

The Board remands the claims for service connection for asbestosis and chronic obstructive pulmonary disease (COPD) due to inadequate medical opinions regarding the relationship between these conditions and the Veteran's military service, including potential asbestos exposure.

The Board granted an initial rating of 100 percent for COPD with asthma from July 23, 2012, to May 21, 2019, and a 60 percent rating as of May 22, 2019. The claim for an initial rating over 30 percent for left eye amblyopia was denied.

The Board denied service connection for a digestive disability, an acquired psychiatric disorder, and chronic obstructive pulmonary disease (COPD) as the evidence did not support a finding that these conditions were related to the Veteran's active duty.

The Veteran withdrew his appeal for all service connection and increased rating claims, resulting in the dismissal of these matters without prejudice.

The Veteran withdrew his appeal at the Board hearing, and the appeal is dismissed.

The Board remands the claim for a respiratory disability, to include COPD, chronic bronchitis, and asthma, for an addendum opinion addressing the etiology of the Veteran's condition.

The Board denied the Veteran's claim for service connection for a respiratory condition, including COPD, due to in-service ammonia inhalation and herbicide exposure.

The Board remands the claim for service connection for DIC as new and relevant evidence was submitted after the August 2007 rating decision.

The 100 percent rating for lung cancer was discontinued effective November 1, 2024, as the Veteran's lung cancer is in remission and no longer active. The claim for a compensable disability rating for lung cancer residuals has been remanded.

The Veteran's respiratory disability was granted a 100 percent rating from December 27, 2023, and the TDIU claim prior to that date was denied.

The Board denied service connection for COPD, atrial fibrillation, squamous cell carcinoma, lymphosarcoma, and lung cancer as they were not related to the Veteran's military service.

The appeal for service connection for benign prostatic hyperplasia, elevated PSA, and erectile dysfunction was withdrawn by the Veteran. The claims for chronic kidney disease, COPD, and headaches were remanded for further development.

The Board granted service connection for chronic obstructive pulmonary disease (COPD) based on the evidence being at least evenly balanced as to whether it is related to toxic exposures during active duty.

The Board granted service connection for lung scarring and remanded the other issues for further development.

The Board denied service connection for chronic obstructive pulmonary disease (COPD) and malignant neoplasm status post right upper and middle lobectomy, finding no evidence linking these conditions to the Veteran's military service.

The Board remands the claim for a recurrent pulmonary disability to ensure that there is a complete record upon which to decide the claim, including obtaining a thorough and contemporaneous medical examination.

The Board dismissed the appeal for service connection for COPD and denied earlier effective dates on a presumptive basis for diabetes mellitus, but granted an earlier effective date for coronary artery disease. The Board also granted an increased rating from August 10, 2022 for diabetes mellitus.

The Board granted service connection for bilateral hearing loss and tinnitus, but denied service connection for chronic obstructive pulmonary disease (COPD) and emphysema.

The Board denied the Veteran's claim for a rating in excess of 30 percent for bronchial asthma with COPD and sarcoidosis based on the medical evidence showing FEV-1 percentages that did not meet the criteria for higher ratings.

The Board remands the claims for service connection and initial rating of various disabilities, including gastrointestinal issues, hearing loss, vertigo, asthma, celiac disease, bronchitis, COPD, sinusitis, and allergic rhinitis, due to a need for additional evidence.